ECHA: Non-Animal Tests For Complex Toxicity Endpoints Not 'Foreseeable'

Animal-welfare groups are concerned that a new report from the European Chemicals Agency on the regulatory applicability of alternative tests "weighs too heavily on the challenges faced in applying data from non-animal methods." The timing, with the REACH 2018 registration deadline looming, also is worrisome, they suggest.

Animal Testing_1200

The European Chemicals Agency has reported previously on non-animal testing approaches that companies are using to comply with data requirements under EU laws, but for the first time the agency offers commentary on the "regulatory applicability" of available alternative methods in a report issued Nov. 22.

According to ECHA's same-day release, significant scientific developments and evolving industry practices over the past decade have reduced...

More from Europe

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By 

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

German Switch Committee Supports OTC Melatonin And Acyclovir, Rejects Rupatadine

 
• By 

Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By 

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

Haleon Invests In State-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”

More from Geography

Viatris Switches Innovative Dual Action Nasal Spray In The UK

 
• By 

Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.

Haleon Survey Finds Brits Not Paying Enough Attention To Gum Health

 
• By 

Gum health awareness among British consumers could be better, a recent Haleon survey finds.

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By 

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.